1Suppliers
5Customers
2Debt Items
20Related Chains

Source-Backed Evidence Depth

Alkermes plc (ALKS) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

9Total relationships
1Distinct source URLs
5High confidence
0.770Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Alkermes plc Suppliers

TickerNameConfidenceEvidence
AMRX Amneal Pharmaceuticals, Inc. 85% Reciprocal relationship from AMRX graph: Reciprocal relationship from ALKS graph: Reciprocal relationship from AMRX graph: Reciprocal relationship from ALKS graph: Reciprocal relationship from AMRX g…

Alkermes plc Customers

TickerNameConfidenceEvidence
SPECIALTY-PHARMACIES SPECIALTY-PHARMACIES 90% Product sales, net are recognized when the customer obtains control of the product, which is when the product has been received by the customer. During the three months ended March 31, 2026 and 2025,…
BAC Bank of America Corporation 62% Reciprocal relationship from BAC graph: Reciprocal relationship from ALKS graph: on quoted market price indications (Level 2 in the fair value hierarchy) and which may not be representative of actual…
JOINT-BOOKRUNNER-BOFA-SECURITIES-INC JOINT-BOOKRUNNER-BOFA-SECURITIES-INC 62% on quoted market price indications (Level 2 in the fair value hierarchy) and which may not be representative of actual values that could have been, or will be, realized in the future, was $ 1,542.6 m…
TOPCO-BORROWER-ALKERMES-INC TOPCO-BORROWER-ALKERMES-INC 62% on quoted market price indications (Level 2 in the fair value hierarchy) and which may not be representative of actual values that could have been, or will be, realized in the future, was $ 1,542.6 m…
U-S-BORROWER-ALKERMES-FINANCE-LLC U-S-BORROWER-ALKERMES-FINANCE-LLC 62% on quoted market price indications (Level 2 in the fair value hierarchy) and which may not be representative of actual values that could have been, or will be, realized in the future, was $ 1,542.6 m…

Alkermes plc Debt Obligations

InstrumentDescriptionConfidenceEvidence
ALKS-DEBT-7681 Xbrl Convertible 90% xbrl convertible detail from xbrl 2013-03-31.
ALKS-DEBT Debt stack $1.5B 90% Market cache reports total debt of $1.5B.

Alkermes plc Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Alkermes plc.

Alkermes plc Ownership

HolderNameConfidenceEvidence
ALKS-OWNER-BLACKROCK-INC BlackRock, Inc. 90% 13F overlay lists BlackRock, Inc. as top holder; 390 tracked holders.

Alkermes plc Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
BAC Bank of America Corporation 100.00 1 ['customer']
RDY Dr. Reddy's Laboratories Limited 100.00 2
ALK Alaska Air Group, Inc. 50.00 2
CHRS Coherus Oncology, Inc. 50.00 2
DXR Daxor Corporation 50.00 2
HIW Highwoods Properties, Inc. 50.00 2
SPH Suburban Propane Partners, L.P. 50.00 2
UP Wheels Up Experience Inc. 50.00 2
BML-PG Bank of America Corporation 50.00 2
GOOD Gladstone Commercial Corporation 50.00 2
JANX Janux Therapeutics, Inc. 50.00 2
KFRC Kforce Inc. 50.00 2
UTZ Utz Brands, Inc. 50.00 2
OCS Oculis Holding AG 50.00 2
SEPN Septerna, Inc. 50.00 2
MLYS Mineralys Therapeutics, Inc. 50.00 2
SPRY ARS Pharmaceuticals, Inc. 50.00 2
SENEB Seneca Foods Corporation 50.00 2
VERA Vera Therapeutics, Inc. 50.00 2
ROAD Construction Partners, Inc. 50.00 2
🔐
ALKS
Unlock ALKS Supply Chain Data
Verified relationships include:
AMRXAmneal Pharmaceuticals, Inc.Supplier85%
SPECIALTY-PHARMACIESSPECIALTY-PHARMACIESCustomer90%
BACBank of America CorporationCustomer62%
+5 more relationships locked
Subscribe — View plans →